The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2026 / August / From Training Burden to Training Value 
Business & Regulation Development & Clinical Regulation & Standards Business & Trends Technology & Manufacturing Sponsored

From Training Burden to Training Value 

Why effective study training depends on relevance, timing, and oversight.

08/14/2026 0 min read Interview

Share

Study training is essential to clinical trial compliance, but assigning, tracking, and documenting it across global studies can consume time better spent improving training quality and impact. Reducing that burden helps ensure that each person receives the right training at the right time.

Tine De Pla of Amgen and Aidan Gannon of Veeva Systems discuss how role-based automation can strengthen oversight, reduce unnecessary training, and deliver more timely, useful learning. They also explore the links between effective training, patient safety, trial execution, and data quality.

Watch the interview.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Can Clinical Trials Collect Less Data Without Compromising Safety?
Industry News Development & Clinical Regulation & Standards
Can Clinical Trials Collect Less Data Without Compromising Safety?

October 22, 2026

5 min read

Rob DiCicco discusses how FDA–industry collaboration is helping sponsors rethink safety reporting, selective safety data collection, and pragmatic clinical trial design.

Choosing a Sterile Fill-Finish Partner
Outsourcing
Choosing a Sterile Fill-Finish Partner

October 22, 2026

5 min read

Alcami’s Kerrie Powell, Senior VP of Sales, discusses the challenges of sterile biologics manufacturing and what sponsors should look for in a CDMO partner

How Genomics Is Personalizing Drug Discovery
Drug Discovery Development & Clinical Interviews
How Genomics Is Personalizing Drug Discovery

October 20, 2026

4 min read

Regeneron Genetics Center’s Luca Lotta explains how population-scale genetic evidence can reveal more promising drug targets and open new possibilities for disease prevention

Inside Kindeva’s New Sterile Fill-Finish Facility
Facilities & Equipment
Inside Kindeva’s New Sterile Fill-Finish Facility

October 20, 2026

5 min read

John Wichelt discusses Kindeva’s Bridgeton facility, supporting injectable programs from clinical development through commercial manufacturing, and choosing a long-term fill-finish partner

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: